These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3040443)

  • 1. Neuropeptide Y modulates adrenergic neurotransmission by an endothelium dependent mechanism.
    Daly RN; Hieble JP
    Eur J Pharmacol; 1987 Jun; 138(3):445-6. PubMed ID: 3040443
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of cadmium on adrenergic neurotransmission in vitro.
    Williams BJ; Laubach DJ; Nechay BR; Steinsland OS
    Life Sci; 1978 Nov; 23(19):1929-33. PubMed ID: 214655
    [No Abstract]   [Full Text] [Related]  

  • 3. Pre- and postjunctional potentiation of the adrenergic neurotransmission by angiotensin II in the perfused rabbit kidney.
    Ekboir AS; Enero MA
    Gen Pharmacol; 1980; 11(4):395-402. PubMed ID: 6249697
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuropeptide Y: an adrenergic cotransmitter, vasoconstrictor, and a nerve-derived vascular growth factor.
    Zukowska-Grojec Z
    Adv Pharmacol; 1998; 42():125-8. PubMed ID: 9327862
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of atherosclerosis on neuromodulation of sympathetic neurotransmission by neuropeptide Y and calcitonin gene-related peptide in the rabbit mesenteric artery.
    Stewart-Lee AL; Aberdeen J; Burnstock G
    Eur J Pharmacol; 1992 Jun; 216(2):167-74. PubMed ID: 1327811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the mechanism of neuropeptide Y induced potentiation of neurogenic vasoconstriction in the isolated rabbit ear artery.
    Duesler JG; Daly RN; Hieble JP
    Am J Hypertens; 1990 Oct; 3(10):796-9. PubMed ID: 2121165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An electrophysiological study on the effect of neuropeptide Y on sympathetic neurotransmission in guinea pig vas deferens.
    Cheung DW; Dukkipati R
    J Pharmacol Exp Ther; 1991 Jun; 257(3):979-83. PubMed ID: 1675292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y accounts for sympathetic vasoconstriction in guinea-pig vena cava: evidence using BIBP 3226 and 3435.
    Malmstrom RE; Lundberg JM
    Eur J Pharmacol; 1995 Dec; 294(2-3):661-8. PubMed ID: 8750731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of neuropeptide Y on adrenergic and non-adrenergic, non-cholinergic responses in the rat anococcygeus muscle.
    Vila E; Tabernero A; Fernandes F; Salaices M
    Br J Pharmacol; 1992 Sep; 107(1):66-72. PubMed ID: 1330166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelium removal does not affect potentiation by neuropeptide Y in rabbit ear artery.
    Budai D; Vu HQ; Duckles SP
    Eur J Pharmacol; 1989 Sep; 168(1):97-100. PubMed ID: 2583236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No effect of D-myo-inositol-1,2,6-triphosphate on vasoconstriction evoked by neuropeptide Y and non-adrenergic sympathetic nerve stimulation.
    Pernow J; Modin A; Lundberg JM
    Eur J Pharmacol; 1992 Nov; 222(1):171-4. PubMed ID: 1468494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of neuropeptide Y-induced augmentation of noradrenaline-induced vasoconstriction by D-myo-inositol 1,2,6-trisphosphate in the rat mesenteric arterial bed.
    Ralevic V; Edvinsson L; Burnstock G
    Acta Physiol Scand; 1994 Jul; 151(3):309-17. PubMed ID: 7976403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide Y receptor subtypes, Y1 and Y2.
    Wahlestedt C; Grundemar L; Håkanson R; Heilig M; Shen GH; Zukowska-Grojec Z; Reis DJ
    Ann N Y Acad Sci; 1990; 611():7-26. PubMed ID: 2174225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of neuropeptide Y on the response of isolated blood vessels to norepinephrine and sympathetic field stimulation.
    Hieble JP; Duesler JG; Daly RN
    J Pharmacol Exp Ther; 1989 Aug; 250(2):523-8. PubMed ID: 2668503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NPY modulates neurotransmission of CGRP-containing vasodilator nerves in rat mesenteric arteries.
    Kawasaki H; Nuki C; Saito A; Takasaki K
    Am J Physiol; 1991 Sep; 261(3 Pt 2):H683-90. PubMed ID: 1653537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interference between adrenergic and non-adrenergic non-cholinergic neurotransmission in mammalian heart.
    Amerini S; Rubino A; Mantelli L; Ledda F
    Pharmacol Res; 1992; 25 Suppl 1():3-4. PubMed ID: 1324489
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuropeptide Y (NPY): a vasoconstrictor in the eye, brain and other tissues in the rabbit.
    Nilsson SF
    Acta Physiol Scand; 1991 Apr; 141(4):455-67. PubMed ID: 1678907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of neuropeptide Y on hemodynamics of the rabbit lung.
    Lang SA; Maron MB
    J Appl Physiol (1985); 1998 Feb; 84(2):618-23. PubMed ID: 9475874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of prejunctional NPY receptor-mediated inhibition of cardiac neurotransmission.
    Serone AP; Wright CE; Angus JA
    Br J Pharmacol; 1999 May; 127(1):99-108. PubMed ID: 10369461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y preferentially potentiates responses to adrenergic nerve stimulation by increasing rate of contraction.
    Vu HQ; Budai D; Duckles SP
    J Pharmacol Exp Ther; 1989 Dec; 251(3):852-7. PubMed ID: 2600818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.